MedTrace Logo

UBT as a Diagnostic Tool for HP Prevalance

NCT02570776 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-10-07

No results posted yet for this study

Summary

The prevalence of H. pylori infection in Pakistan is unknown and investigators want to assess it in dyspeptic patients utilizing UBT. At the same time investigators want to validate UBT sensitivity and specificity in Pakistani patients

Conditions

  • Dyspepsia

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • National Institute of Liver & GI Diseases, Pakistan

    lead OTHER

Principal Investigators

  • Zahid Azam, FCPS, MSc · National Institute of Liver & GI Diseases, Dow University of Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-12-31
Completion
2016-02-29

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570776 on ClinicalTrials.gov